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Capturing the wide variety 
of impaired fracture healing 
phenotypes in Neurofibromatosis 
Type 1 with eight key factors: a 
computational study
A. Carlier1,2, H. Brems4, J.M.A. Ashbourn5, I. Nica6, E. Legius4 & L. Geris1,2,3
Congenital pseudarthrosis of the tibia (CPT) is a rare disease which normally presents itself during 
early childhood by anterolateral bowing of the tibia and spontaneous tibial fractures. Although the 
exact etiology of CPT is highly debated, 40–80% of CPT patients are carriers of a mutation in the 
Neurofibromatosis Type 1 (NF1) gene, which can potentially result in an altered phenotype of the skeletal 
cells and impaired bone healing. In this study we use a computational model of bone regeneration to 
examine the effect of the Nf1 mutation on bone fracture healing by altering the parameter values of 
eight key factors which describe the aberrant cellular behaviour of Nf1 haploinsufficient and Nf1 bi-
allelically inactivated cells. We show that the computational model is able to predict the formation 
of a hamartoma as well as a wide variety of CPT phenotypes through different combinations of 
altered parameter values. A sensitivity analysis by “Design of Experiments” identified the impaired 
endochondral ossification process and increased infiltration of fibroblastic cells as key contributors to 
the degree of severity of CPT. Hence, the computational model results have added credibility to the 
experimental hypothesis of a genetic cause (i.e. Nf1 mutation) for CPT.
Congenital pseudarthrosis of the tibia (CPT) is a rare disease which normally presents during early infancy. It 
is characterised by anterolateral bowing of the tibia and develops into spontaneous fractures in the distal third 
of the tibia1. Usually the bone regeneration is insufficient and a pseudarthrosis is formed at the fracture site. 
Conventionally, CPT is treated surgically by the physical excision of the abnormal bone tissue (also described as 
the ‘hamartoma’) and internal or external fixation1. Failure to maintain a bony union is however common, result-
ing in multiple revision surgeries and occasionally amputation of the lower leg.
The exact etiology of CPT is still highly debated. However, both the fibrous hamartoma as well as the patho-
logically thick periosteum are believed to prevent the formation of a bony union due to mechanical interposition 
and hampered vascularisation2. Also, 40-80% of CPT patients are carriers of a mutation in the NF1 gene whereas 
the incidence of CPT is less than 4% in patients with a NF1 gene mutation3–5 (note that in a clinical setting rig-
orous genetic screening is often lacking which might lead to undetected NF1 mutations in CPT patients). It has 
been postulated that a double inactivation of the NF1 gene is necessary for the development of a pseudarthro-
sis6,7, and that the relative proportion of NF1 haploinsufficient cells and NF1 bi-allelically inactivated cells in the 
pseudarthrosis region will determine the healing outcome. Hence, the altered phenotype of mutated skeletal 
cells may also contribute to the observed impaired bone healing in patients with a NF1 gene mutation (Fig. 1A). 
The NF1 gene encodes neurofibromin, an ubiquitous protein expressed in osteoblasts, osteoclasts, chondrocytes, 
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fibroblasts and endothelial cells1,8. Neurofibromin negatively regulates the activity of Ras, a protein involved in 
cellular proliferation and differentiation1,2. One of the cellular deficiencies is the recurrent invasion and increased 
proliferation of fibrous lesion cells, thereby physically preventing bony bridging1. In addition, the matrix pro-
duction of the lesionous chondrocytes is affected which hampers endochondral bone repair1. Furthermore, the 
mutated osteoprogenitor cells show inferior osteogenic differentiation while excessive generation of osteoclasts 
may compromise any attempt at bone repair1,9. Finally, lesionous endothelial cells may interfere with normal bone 
healing through an altered blood supply1,10.
Clearly, an improved understanding of the role of NF1 haploinsufficient and NF1 bi-allelically inactivated 
skeletal cells in impaired bone healing is crucial for the development of targeted therapies for CPT patients. Since 
the Nf1 mutation leads to deficiencies in many skeletal cell types, we hypothesise that computational models are 
a suitable tool to investigate the influence of these deficiencies on the bone healing outcome11,12. Furthermore, 
Figure 1. Schematic representation, geometrical domain and boundary conditions of the computational 
model. (A) Schematic illustration of the cellular basis contributing to poor bone repair (adapted from1). 
(B) Scale separation map indicating schematically the modelled processes at different spatial and temporal 
scales. m = mf + mc + mb represents the total tissue density. The intracellular variables govern the endothelial 
cell (EC) behaviour. At the tissue scale, cells can migrate (only mesenchymal stem cells (MSCs) and fibroblasts), 
proliferate (circular arrows), differentiate (vertical arrows), produce growth factors and extracellular matrix. 
Blood vessels are a source of oxygen which influences proliferation, differentiation and hypoxia-dependent 
angiogenic growth factor production. Variables influencing a tissue level process are indicated next to the 
corresponding arrow. The processes that are down- and upregulated due to the Nf1 mutation are labeled with ‘X’ 
for understimulation and ‘!!’ for overstimulation respectively. (C) The geometrical domain models a quarter of 
the real fracture callus geometry19 due to symmetry: 1 periosteal callus; 2 intercortical callus; 3 endosteal callus; 
4 cortical bone ends. (D) Dirichlet boundary conditions are assumed for the mesenchymal stem cells (cm) and 
fibroblasts (cf) which are released from the periosteum, surrounding soft tissues and bone marrow20, and for the 
osteochondrogenic growth factor (gbc) which is released from the degrading bone ends and the cortex21,22. The 
origin of the coordinate system is placed in the left bottom corner of the geometrical domain.
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a computational model allows the investigation of both individual as well as combined effects of altered cel-
lular phenotypes, something that is near impossible to achieve experimentally. Hence, this study will use a 
well-established multiscale computational model of normal bone regeneration13–16 to investigate the impaired 
bone healing associated with Nf1, in particular the formation of a pseudarthrosis after excessive bowing and 
pathological fracture, and to improve our fundamental understanding.
Materials and Methods
The multiscale computational model of bone regeneration was established previously and has been described in 
detail elsewhere14,17. In brief, at the tissue level the various key processes of bone regeneration are captured with 
10 partial differential equations (PDEs) of the taxis-reaction-diffusion type which describe the evolution in time 
and space of the mesenchymal stem cell density (cm), fibroblast density (cf), chondrocyte density (cc), osteoblast 
density (cb), fibrous matrix density (mf), cartilaginous matrix density (mc), bone matrix density (mb), generic oste-
ochondrogenic growth factor concentration (gbc), vascular growth factor concentration (gv) and oxygen tension 
(n). Note that only one generic osteochondrogenic growth factor (gbc) is included, which represents the effect of 
multiple growth factors present in the fracture callus. The influence of this generic growth factor on differentia-
tion is either chondrogenic or osteogenic depending on the local oxygen tension.
The formation of the blood vessel network is modelled at the level of the individual endothelial cell with a 
discrete agent-based approach. The computational model includes three different processes that determine the 
development of the discrete vascular tree, i.e. sprouting (the formation of a new branch, headed by a “tip cell” or 
“leader cell”), vascular growth (the extension of the branch due to the growth of “stalk cells” or “follower cells”) 
and anastomosis (the fusion of two branches). The sprouting behaviour of the endothelial cells is derived from 
the agent-based model of Bentley et al.18 and is captured with eight intracellular variables, which are unique to 
every endothelial cell (Fig. 1B). The growth of a blood vessel is modelled by computing the movement of the 
corresponding tip cell where the tip cell speed depends on the active VEGFR-2 concentration and the tip cell 
direction is influenced by chemotactic (angiogenic growth factor) and haptotactic (collagen fibres in the extracel-
lular matrix) signals. When a tip cell encounters another blood vessel or when it migrates outside the geometrical 
domain (illustrated in Fig. 1C–D), an anastomosis is formed during which the leading endothelial cell loses its tip 
cell phenotype. The newly established connection between the vessels allows for blood flow and the delivery of 
oxygen and nutrients. Only the endothelial cells that are part of a vascular loop are sources of oxygen.
The geometrical domain of the computational model is deduced from the real callus geometry at three weeks 
post-fracture in a standardised femoral rat fracture model19. We assume a simplified axisymmetrical representa-
tion of the geometry so that only a quarter of the domain is simulated (Fig. 1C–D). The parameter values are 
derived from extensive literature reviews where possible and estimated if no relevant data was available13–16. Both 
the model variables and the parameter values were non-dimensionalised using proper scaling factors and will 
be described in their non-dimensionalised form throughout this work13–16. After non-dimensionalisation, the 
system was also complemented by suitable initial and boundary conditions to ensure the existence, uniqueness 
and non-negativity of the solution (Fig. 1D).
To examine the effect of the Nf1 mutation on bone fracture healing, the parameter values of the factors 
describing the aberrant cellular behaviour of Nf1 haploinsufficient and Nf1 bi-allelically inactivated cells were 
altered (Table 1). A wide range of parameter values (Nf1 range) was investigated to account for the variable pro-
portion of Nf1 haploinsufficient and Nf1 bi-allelically inactivated cells in the pseudarthrosis region. In particular, 
a larger deviation of the parameter values from the normal case represents a higher proportion of bi-allelically 
inactivated cells. In the current study we have investigated the influence of eight factors described in the litera-
ture as contributors to the poor fracture healing outcome in CPT. These factors include the increased invasion of 
fibrous lesion cells (cf,BC)1, increased fibroblastic proliferation (Af0)1, increased fibroblastic differentiation (F4)23, 
reduced osteogenic differentiation (Y11)1,9, reduced endochondral ossification (Y3,cb)1, reduced cartilage formation 
(Pmc)1, increased fibrous tissue formation (Pmf)23 and increased angiogenic growth factor production (Ggvc)1,10.
In order to determine the (relative) importance of the eight factors listed in Table 1, a large sensitivity analysis 
using “Design of Experiments” (DOE) was conducted24,25. DOE (or experimental design) is a statistical tool that 
generates an array of combinations of different parameter values within a predefined parameter space. Next, the 
Factor Symbol
Normal 
case
Nf1 
case
Nf1 
range
Invasion time fibroblasts cf,BC 3 20 0–50
Fibroblastic proliferation Af0 0.1 2 0.1–10
Fibroblastic differentiation F4 0.01 0.2 0.01–1
Osteogenic differentiation Y11 20 1 0–20
Endochondral ossification Y3,cb 1000 50 0–1000
Cartilage formation Pmc 0.2 0.02 0–0.2
Fibrous tissue formation Pmf 0.2 2 0.2–10
Angiogenic growth factor 
production Ggvc 10
3 5.104 103–105
Table 1.  Parameter values of the factors describing the aberrant cellular behaviour of Nf1 mutated cells. 
The parameter values of the normal case were derived from extensive literature reviews where possible and 
estimated if no relevant data was available as detailed in previous publications13–16. The parameter ranges of the 
Nf1 case were estimated from the experimental findings described in literature1,9,23,1,10.
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computer simulations were performed with these parameter combinations, utilizing high-performance compu-
tational resources provided by the VSC (Flemish Supercomputer Center). Finally the results were statistically 
analysed. Since the computational model of bone regeneration is highly non-linear and uniform designs also 
cope well with the addition and removal of runs, a uniform design was chosen for the sensitivity analysis. The 
parameter space (Table 1, Nf1 range) was determined by varying the parameter values of the eight factors mostly 
in one direction with respect to the normal case, in this way biasing the DOE design to a CPT phenotype. Using 
the parameter ranges listed in Table 1 (Nf1 range), a uniform design with 200 runs, i.e. 200 parameter combina-
tions, was generated (see also supplementary material). The space-filling design evenly spreads out the parameter 
combinations over the eight-dimensional parameter space which can be checked with scatterplots and histograms 
(Fig. 2).
The responses (i.e. model outcomes) that were studied in the sensitivity analysis are listed in Table 2 (see also 
supplementary material). In order to calculate the tissue fractions, the spatial images were first made binary using 
tissue-specific thresholds (0 means that the tissue is not present and 1 means that the tissue is present in a grid 
cell). Subsequently, an equal weight was assigned to the different tissues, i.e. if a grid cell contained three tissues, 
the area of that grid cell was divided by three in the final calculations of the tissue (area) fractions. Since a pseu-
darthrosis is defined by the tissues present in the fracture gap area (1a-2-3a in Fig. 1D), all the responses were 
calculated for this area. An additional response “CI” (complication index) was introduced to assess the degree of 
severity of CPT (Equation 1). More specifically, the CI (γ7) combines two continuous responses (i.e. the amount 
of fibrous tissue γ4 and fibroblasts γ5, each varying between 0 and 1 for a low and high amount respectively) with 
a Boolean response γ6 (i.e. bony union or non-union represented by 0 or 1 respectively):
γ
γ γ γ
=
+ +
( )3 17
4 5 6
A typical parameter combination for which the value of the CI is small is one or which the degree of severity 
of CPT is small, or in other words, when the fracture healing proceeds fairly normally. Conversely, a typical 
Figure 2. Uniformity of the distribution in a uniform design. (A) Histogram showing the distribution of the 
parameter rate of cartilage formation (Pmc) and the invasion time of fibroblasts (cf,BC) in a uniform design. In this 
particular example, it can be seen that the distribution of the cartilage formation rate (Pmc) is uniform, while for 
the invasion time of fibroblasts (cf,BC), a smaller number of high values are included in the uniform design. (B) 
Scatterplot of all parameter combinations. The parameter combinations are spread out over the entire parameter 
space.
Response Symbol Type Day 7 Day 21 Day 35 Day 49
Bone tissue fraction γ1 Continuous 0%–100% 0%–100% 0%–100% 0%–100%
Fibrous tissue fraction γ2 Continuous 0%–100% 0%–100% 0%–100% 0%–100%
Cartilage tissue fraction γ3 Continuous 0%–100% 0%–100% 0%–100% 0%–100%
Fibrous tissue γ4 Continuous 0–1 0–1 0–1 0–1
Fibroblasts γ5 Continuous 0–1 0–1 0–1 0–1
Non-union γ6 Boolean 0/1 0/1 0/1 0/1
CI γ7 Continuous 0–1 0–1 0–1 0–1
Table 2.  Analysed responses and their range of possible values.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:20010 | DOI: 10.1038/srep20010
parameter combination for which the value of the CI is large, is one for which the degree of severity of CPT is 
large, or in other words, when the fracture healing is severely impaired.
The uniform designs were generated and analysed with JMP (SAS Institute Inc., Cary, North Carolina, USA) 
using a Gaussian process with a Gaussian covariance function. Unlike an ANOVA-type of analysis, Gaussian 
processes do not only estimate the importance of individual parameters, but also the influence of the parame-
ters on the outcome of a model. Hence, a Gaussian process will determine the best-fitting statistical model that 
can predict the model outcome for a certain combination of input parameters (Figs 3–5). Since the result of a 
Gaussian process is a statistical model, care should be taken when interpreting the predictions. In order to assess 
the accuracy of the statistical predictions an actual versus predicted plot generated by JMP is helpful. In this plot 
the actual results, i.e. the outcomes calculated by the computational model, are compared with those predicted by 
the statistical model (Fig. 3). In a perfect statistical fit, all the points would be located on a 45-degree line. Fig. 3 
(left) shows that the statistical model predicts a good fit for the CI response on Day 7. However, the Gaussian 
model does not capture the number of fibroblasts on Day 7 well, as illustrated by the large deviations from the 
45-degree line in Fig. 3 (right). Since the statistical predictions are accurate for all outcomes except the number of 
fibroblasts on Day 7 and Day 21 (results not shown), the results on the number of fibroblasts on Day 7 and Day 21 
will not be used for further interpretation.
Results
A non-union resembling a CPT phenotype was predicted by the computational model when all the parameter 
values were altered according to Table 1 (Nf1 case). Due to the hampered osteogenic and endochondral ossifi-
cation, a limited number of osteoblasts were formed resulting in a non-union (Fig. 4C–F). The fracture site was 
however predicted to be filled with chondrocytes and fibroblasts which resulted in the formation of a fibrocar-
tilaginous ‘hamartoma’ (Fig. 4D,E). Although plenty of chondrocytes were present, the amount of cartilage was 
limited due to the impaired formation of cartilage matrix (Fig. 4B).
The main effects, i.e. the most important factors that influence a specific outcome of the model, are summa-
rised in Table 3. Note that the number of fibroblasts on Day 7 and Day 21 were not well predicted by the statistical 
model and thus not used for further interpretation. Since the bone tissue fraction was zero on Day 7, the statistical 
model did not calculate any main effects for this response. The most important factors influencing the defined 
responses were Pmc (rate of cartilage formation), Af0 (rate of fibroblastic proliferation), Pmf (rate of fibrous tissue 
formation), cf_BC (duration of fibroblast invasion) and Y3cb (rate of endochondral ossification). The factors F4 
(rate of fibroblastic differentiation), Y11 (rate of osteogenic differentiation) and Ggvc (rate of angiogenic growth 
factor production) contributed less to the outcomes of the defined response space. The factor Pmc influenced all 
outcomes except the amount of fibrous tissue on Day 7 and the CI on Day 7. As a result this factor appeared to be 
crucial for the fracture healing outcome and was studied in more detail.
In order to study the main effects of the CI response in more detail, marginal model plots are a helpful tool. 
These plots show the actual and predicted values of the output variable as a function of only one factor when 
disregarding the influence of other factors. Figure 5 shows the marginal model plots for the CI value as a function 
of cf_BC, Af0, F4, Y11, Y3cb, Pmc, Pmf and Ggvc. Firstly, it can be noted from Figs 5–6 that a wide range of CI values 
(0.01-0.89) were predicted by the computational model. Secondly, Fig. 5 shows that the dots, indicating the actual 
values of the CI response, split into two classes, one for which the CI value was high, resulting in impaired heal-
ing and one for which the CI value was low. For the factors cf_bc, Af0, F4, Y11, Pmf, Ggvc, dots were present in both 
classes, regardless of their respective parameter values. However, for cartilage formation (Pmc) values below 0.05 
and endochondral ossification (Y3cb) values below 200, the CI value was always high, leading to an impaired bone 
healing phenotype (Fig. 5, arrows). Therefore, Y3cb and Pmc discriminated between the two classes (which also 
corresponded to the results of Table 3).
Y3cb and Pmc also discriminated between the high and low CI values on Day 35 and Day 49 (Fig. 6). However, 
on Day 35 and Day 49 some low CI values were predicted for Pmc and Y3cb parameter values below 0.05 and 200 
respectively (Fig. 6, arrows). A closer look at the marginal model plots of the CI value on Day 49 showed that the 
Figure 3. Actual versus predicted plot for the CI response (left) and the fibroblast density (right) on Day 7. 
The horizontal axis shows the value of the output predicted by the Gaussian process and the vertical axis shows 
the actual output value of the computational model.
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influence of Y3cb and Pmc can be modulated by other factors (Fig. 7). The green circle shown in Fig. 7 represents a 
single case where a low CI value was calculated even though the cartilage formation (Pmc) value was low. Indeed, 
the limited cartilage production rate (Pmc) was compensated by a relatively high endochondral ossification rate 
(Y3cb). Furthermore, the duration of fibroblast infiltration (cf_BC) and the rate of fibroblast proliferation (Af0) were 
low, which resulted in a small number of fibroblasts and a low CI value.
Figure 4. The spatiotemporal evolution of fracture healing associated with Nf1 as predicted by the 
computational model with the parameter set defined in Table 1 (Nf1 case). (A) fibrous MD (× 0.1 g/ml), (B) 
cartilage MD (× 0.1 g/ml), (C) bone MD (× 0.1 g/ml), (D) fibroblastic CD (× 106 cells/ml), (E) chondrocytic 
CD (× 106 cells/ml), (F) osteoblastic CD (× 106 cells/ml), (G) oxygen tension (× 1%), (H) active vasculature. 
MD = matrix density, CD = cell density. Similarly to previous work, the various tissues (i.e. bone, cartilage and 
fibrous matrix) and cell types (i.e. fibroblasts, osteoblasts, and chondrocytes) can be present within the same 
grid cell since their respective densities are constrained independently of the presence of other tissues or cell 
types14–17.
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Interestingly, cf_BC values below 10 led to intermediate values of the CI response (Fig. 8, arrow). The actual dots 
still belonged to the upper class but did not span the entire range of high CI values. Moreover, the CI values of 
these simulations were even reduced on Day 35 and Day 49. Consequently, a non-dimensional value of cf_BC above 
10 was imperative for CI values above 0.5 and especially at later time points.
Discussion
In this study we used a computational model of bone regeneration to investigate impaired fracture healing asso-
ciated with Nf1. To the best of the authors’ knowledge, the model is the first in this field and shows that the 
combination of aberrant processes in skeletal cells, attributed in the literature to the presence of a Nf1 muta-
tion, may lead to the prediction of a pseudarthrosis. Indeed, the computational model predicts the formation 
of a non-union (Fig. 4C), a key characteristic of a pseudarthrosis2, by altering the parameter values of eight key 
factors. Furthermore, the predicted tissues are highly reminiscent of a hamartoma, including a large quantity of 
fibrous tissue, some cartilage and limited endochondral ossification26 (Fig. 4A–C).
Fibroblasts are predicted to be the major cell type present in the hamartoma (Fig. 4D). However, Cho et al. 
measured fibrous hamartoma cells at different stages of osteoblastic differentiation while maintaining some mes-
enchymal lineage phenotype27. These findings are also supported by the results of Lee et al. that show an aberrant 
growth of Nf1 haploinsufficient periosteal cells which have failed in terminal osteoblastic differentiation28. It is 
further hypothesised that the fibrous hamartoma, a key characteristic of CPT, originates from these compromised 
cells9,28. The discrepancy between the predicted and experimentally measured hamartomatous cell type can be 
explained by the fact that the computational model only describes four distinct cell types: mesenchymal stem 
cells, fibroblasts, chondrocytes and osteoblasts. Both chondrogenic and osteogenic differentiation require specific 
stimuli such as growth factors and specific ranges of oxygen tension whereas fibroblastic differentiation is set as 
the default differentiation pathway in the computational model. As a result, cells that fail to commit to the osteo-
genic or chondrogenic lineage will become fibroblasts and start to produce fibrous tissue.
The relative importance of the eight altered factors to the model outcome was further explored in a large sensi-
tivity analysis using “Design of Experiments” (DOE). As described earlier, DOE (or experimental design) is a sta-
tistical tool that generates an array of combinations of different parameter values within a predefined parameter 
space. Next, the computer simulations are performed with these parameter combinations and finally the results 
are statistically analysed. If all the defined responses are taken together, the most influential factors are: rate of 
cartilage formation (Pmc), rate of fibroblast proliferation (Af0), rate of fibrous tissue formation (Pmf), duration of 
fibroblast invasion (cf_BC) and rate of endochondral ossification (Y3cb) (Table 3). For the CI value specifically, the 
main effects are: rate of cartilage formation (Pmc), duration of fibroblast invasion (cf_BC) and rate of endochondral 
ossification (Y3cb). Interestingly, similar CI values can be obtained through many combinations of altered param-
eter values although the composition and spatial distribution of the tissues within the hamartoma was different 
Response Gaussian covariance function
Fibrous tissue fraction Day 7 Pmc (53%)
Bone tissue fraction Day 7 —
Cartilage fraction Day 7 Pmc (53%)
Fibrous tissue Day 7 Pmf (56%), Af0 (27%)
Fibroblasts Day 7 —
CI Day 7 Pmf (48%), Af0 (31%)
Fibrous tissue fraction Day 21 Pmc (87%)
Bone tissue fraction Day 21 Pmc (25%)
Cartilage fraction Day 21 Pmc (81%)
Fibrous tissue Day 21 Pmc (35%), Cf_BC (20%), Pmf (12%)
Fibroblasts Day 21 —
CI Day 21 Pmc (36%), Y3cb (12%)
Fibrous tissue fraction Day 35 Pmc (77%)
Bone tissue fraction Day 35 Pmc (33%), cf_BC (13%), Y3cb (12%)
Cartilage fraction Day 35 Pmc (34%), Y3cb (12%)
Fibrous tissue Day 35 Pmc (34%), cf_BC (30%)
Fibroblasts Day 35 cf_BC (32%), Pmc (31%), Af0 (11%)
CI Day 35 Pmc (47%), Y3cb (12%)
Fibrous tissue fraction Day 49 Pmc (66%)
Bone tissue fraction Day 49 Pmc (34%), cf_BC (14%), Y3cb (13%)
Cartilage fraction Day 49 Pmc (23%), Y3cb (16%)
Fibrous tissue Day 49 cf_BC (39%), Pmc (27%)
Fibroblasts Day 49 cf_BC (24%), Pmc (15%)
CI Day 49 Pmc (43%), cf_BC (16%)
Table 3.  Results of the uniform design. The main effects that explain at least 10% of the variation in the 
response are listed for each response.
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Figure 5. Marginal model plots for cf_BC, Af0, F4, Y11, Y3cb, Pmc, Pmf and Ggvc. The horizontal axis shows the 
value of the parameter and the vertical axis shows the value of the CI response on Day 21. The dots indicate 
the actual results obtained from the computational model (each dot represents the CI response obtained for a 
particular combination of parameter values in the Nf1 range), and the solid line indicates the results predicted 
by the Gaussian process. Note that the actual results can be split up in two classes: one for which the CI value is 
high, resulting in impaired bone healing and one for which the CI value is low. GF = growth factor.
www.nature.com/scientificreports/
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for each combination (results not shown). Furthermore, the computational model predicts a wide range (0.01-
0.89) of CI values, corresponding to different degrees of severity by which the pseudarthrosis presents. Numerous 
classifications have been described in the literature2, thereby supporting the large degree of heterogeneity of 
CPT. The Crawford classification29 mainly describes the different stages as CPT progresses whereas the Boyd 
classification30 entails a prognostic value and the Apoil 2 stage classification discriminates between the type of 
pseudarthrosis (i.e. hypertrophic or atrophic). The large range of predicted CI values is remarkable, particularly 
if the asymmetrical design of the parameter value ranges is taken into account (Table 1). The parameter values of 
the eight factors were mostly varied in one direction with respect to the normal case, thus biasing the DOE design 
to a CPT phenotype.
Two classes can be observed in the predicted range of CI values, one for which the CI value is high, resulting 
in impaired bone healing and one for which the CI value is low, resulting in normal bone healing. A closer look 
at the marginal model plots of the CI value indicates that the rate of cartilage formation (Pmc), the rate of endo-
chondral ossification (Y3cb) and the duration of fibroblast invasion (cf_BC) are the most important determinants of 
this behaviour which can be explained as follows. In the computational model several aspects of endochondral 
ossification are combined in one function (Y3), which is dependent on the local oxygen tension, the local osteo-
chondrogenic growth factor concentration and the local cartilage density13–16. The latter is included to account 
Figure 6. Marginal model plots for Y3cb and Pmc on Day 21 (A), Day 35 (B) and Day 49 (C). The horizontal 
axis shows the value of the parameter and the vertical axis shows the CI value. The dots indicate the actual 
results obtained from the computational model (each dot represents the CI response obtained for a particular 
combination of parameter values in the Nf1 range), and the solid line indicates the results predicted by the 
Gaussian process. Note that the actual results can be split up in two classes: one for which the CI value is high, 
resulting in impaired bone healing and one for which the CI value is low.
www.nature.com/scientificreports/
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Figure 7. Marginal model plots for cf_BC, Af0, F4, Y11, Y3cb, Pmc, Pmf and Ggvc. The horizontal axis shows the 
value of the parameter and the vertical axis shows the CI value at day 49. The dots indicate the actual results 
obtained from the computational model (each dot represents the CI response obtained for a particular 
combination of parameter values in the Nf1 range), and the solid line indicates the results predicted by the 
Gaussian process. Note that the actual results can be split up in two classes: one for which the CI value is high, 
resulting in impaired bone healing and one for which the CI value is low. The green circles indicate a particular 
case when a low Pmc value is associated with a low CI value. The red circles indicate a particular case when a low 
Pmc value is associated with a high CI value. GF = growth factor.
www.nature.com/scientificreports/
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for the hypertrophy of the chondrocytes. More specifically, a critical cartilage density needs to be reached in the 
computational model before endochondral ossification starts. Since the majority of the bone formation in the 
computational model happens through endochondral ossification, an impairment of that pathway will severely 
affect the bone healing outcome. Hence in retrospect, it is not surprising that the rate of cartilage formation (Pmc) 
and the rate of endochondral ossification (Y3cb) are critical determinants for the CI value. On the one hand, a 
low rate of cartilage formation (Pmc) will delay the onset of the critical cartilage density, delaying endochondral 
ossification and finally resulting in a non-union. On the other hand, a low rate of endochondral ossification (Y3cb) 
directly slows down the endochondral ossification process. Moreover, the rate of endochondral ossification (Y3cb) 
and the rate of cartilage formation (Pmc) cannot be compensated for in the current parameter space of the exper-
imental design whereas a limited duration of fibroblast infiltration can be compensated by other factors in the 
computational model, e.g. by a high rate of fibroblast proliferation or differentiation. The CI value is, however, not 
only affected by the presence of a non-union, but is also determined by the number of fibroblasts and the amount 
of fibrous tissue. An impaired endochondral ossification process is consequently insufficient to result in a high 
CI value. This conclusion was also drawn from Fig. 7 (green circle) where a low rate of cartilage formation (Pmc) 
was associated with a low CI value. Indeed, a minimal duration of fibroblast invasion (cf_BC) is necessary for the 
computational model to result in a sufficient number of fibroblasts and enough fibrous tissue, reminiscent of a 
hamartoma.
The current computational study has some limitations. Firstly, the computational model used in this study 
to explore the mechanisms of impaired healing associated with Nf1 only focuses on the repair phases of frac-
ture healing, i.e. the soft and hard callus phase. As a result, the model does not capture the early inflammatory 
response nor the bone remodelling phase, respectively preceding and succeeding the repair phase. However, a 
pathogenic Nf1 mutation may affect the inflammatory response31. It is also known that a pathogenic Nf1 mutation 
results in increased osteoclastic activity32, leading to an imbalanced bone remodelling process and consequently 
to fracture reoccurrence. The incorporation of the inflammatory and bone remodelling response will be the sub-
ject of a future extension of the computational model.
Secondly, the computational model implicitly assumes that the mechanical environment of the fracture callus 
is permissive, meaning amongst other things that the fracture is sufficiently stabilised to allow bone formation 
(either through intramembranous or endochondral ossification). Hence, we do not consider any mechanoregu-
latory signals in the presented model. Although inadequate mechanical stimulation is not considered to be the 
primary cause of CPT, mechanical stimulation may affect the healing response. Indeed, the fibrous hamartoma 
and the pathologically thick periosteum are believed to prevent bony union due to the mechanical interposition 
and hampered vascularisation2. Moreover, Kühnisch et al. report diminished mechanical strength and increased 
micro-porosity in Nf1Prx1 bone tissue due to increased osteocyte lacuna size33. In addition, the muscle compart-
ment might also be reduced in some NF1 cases, which may limit adequate mechanical stimulation34.
Thirdly, the computational model is based on experimental data from mouse models since these small animal 
models are increasingly used in bone healing studies due to their less expensive housing, shorter breeding cycles, 
well-defined genetic background and available (genetic) methods to study particular molecular mechanisms of 
action35. However, compared to large animals, rodents have a more primitive bone structure without a Haversian 
system and use resorption cavities for bone remodeling35. Moreover, in order to correctly mimic fracture healing 
in adults, animals of an age with completed bone growth should be used36. The ratio of age at growth plate closure 
and life expectancy is about 20% in humans which is quite comparable to that of mice but markedly differs from 
that of other species such as rats (30%), sheep (10%) and dogs (5%)37. In the rat, growth plates have been reported 
to remain open for prolonged periods of time, even throughout the normal life expectancy of the animal37. Given 
that in this study we have focused on the genetic causes of CPT, we believe that a comparison with experimental 
data from genetic mouse models (e.g. Nf1osx−/−, Nf1Prx1 and Nf1Col1 mice) is reasonable, albeit keeping in mind 
the differences that exist between murine and human bone healing. Also, the computational model of bone regen-
eration was used to investigate the wide range of impaired fracture healing phenotypes in the population of Nf1 
subjects rather than focusing on subject-specific effects.
Figure 8. Marginal model plots for cf_BC on Day 21, Day 35 and Day 49. The horizontal axis shows the value 
of the parameter, the vertical axis shows the CI value. The dots indicate the actual results obtained from the 
computational model (each dot represents the CI response obtained for a particular combination of parameter 
values in the Nf1 range), and the solid line indicates the results predicted by the Gaussian process. Note that 
the actual results can be split up in two classes: one for which the CI value is high, resulting in impaired bone 
healing and one for which the CI value is low.
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Fourthly, the following three phenotypical criteria were used to assess the degree of severity of CPT: the 
absence of cortical bridging of the defect, the amount of fibrous tissue and the amount of fibroblasts (Equation 1). 
Clearly the results of the DOE should be interpreted in light of this definition which puts a lot of importance on 
the presence of fibroblasts and fibrous tissue. However, the definition of the CI variable can be readily extended 
once more clinical data becomes available. Finally, as with all statistical tools, care has to be taken when interpret-
ing the results of the DOE analysis. A uniform design of 200 runs was chosen for a balance between statistical 
accuracy and computational feasibility. Furthermore, the results of the sensitivity analysis are valid within the 
chosen parameter and response space.
Taking all the computational results together, it can be stated that an impaired endochondral ossification pro-
cess and an increased infiltration of fibroblastic cells are key elements for the development of a congenital pseu-
darthrosis in the computational model. These computational observations are supported by several experimental 
findings that attribute a crucial role to the hampered endochondral ossification process. For example, Kühnisch 
et al. analysed two conditional mouse models (i.e. Nf1Prx1, limb knock-out and Nf1Col1, osteoblast-specific 
knock-out) and report defective mineral binding in the proximity of blood vessels due to impaired bone col-
lagen formation33. In addition, Kolanczyk et al. report a decreased proliferation and premature hypertrophy of 
the growth plate chondrocytes as well as impaired osteoblast differentiation in the developing limbs of Nf1Prx1 
mice38. A cartilage-specific inactivation of neurofibromin resulted in reduced chondrocyte proliferation in the 
growth plate, delayed endochondral bone formation and increased degradation of chondrocyte extracellular 
matrix39. Similar findings are reported by Kuorilehto et al. who have shown that the highly expressed Nf1 gene 
acts as a Ras-GAP in the growth plate during endochondral ossification as well as in the mature bone cells8. Seitz 
et al. observed a pathological enrichment of the osteoid volume and osteoid surface in the Nf1 biopsies40, accom-
panied by high bone turnover. Since the overactivation of the Ras-MAPK signaling pathway negatively influences 
endochondral ossification8 and osteogenic differentiation27, the pharmaceutical inhibition of this pathway may 
constitute a potential therapeutic strategy. This hypothesis was explored by Ndong et al. who report an improved 
bone healing and increased callus strength in Nf1osx−/− mice that received a MEK inhibitor (i.e. Trametinib) and 
BMP2 released locally at the fracture site through a nanoparticle delivery method41. Similar findings are described 
by El-Hoss et al. who show that MEK inhibition can promote bone formation in combination with rhBMP2 in a 
murine model of Nf1 pseudarthrosis although the amount of fibrosis was not suppressed42. The latter observation 
corresponds to the computational prediction that an increased infiltration of fibroblastic cells can also be a key 
element for the development of a congential pseudarthrosis. Future research is however necessary to confirm this 
preliminary hypothesis through additional experimental validation.
It is to be expected that, since endochondral ossification and cellular infiltration are fundamental bone healing 
processes, they might also be affected in other multiple bone pathologies. However, we believe that the interpreta-
tion of the results in this study should be restricted to congenital pseudarthrosis linked to Nf1 due the particular 
combination of altered factors, reported in the literature to be related to Nf1 induced changes, the bias in the DOE 
design and the specific definition of the complication index.
Conclusion
In this study we used a well-established multiscale computational model of bone regeneration to integrate the 
state-of-the-art experimental knowledge on the effect of the Nf1 mutation on bone fracture healing. We have 
shown that by altering the parameter values of eight key factors, attributed in the literature to the presence of 
a Nf1 mutation, all the distinctive characteristics of a pseudarthrosis can be predicted, i.e. the formation of a 
hamartoma including a large quantity of fibrous tissue, some cartilage and limited endochondral ossification. 
Furthermore, the computational model is able to capture a wide variety of impaired fracture healing phenotypes 
associated with Nf1 through different combinations of altered parameter values. A large sensitivity analysis using 
“Design of Experiments” (DOE) identified that an impaired endochondral ossification process and an increased 
infiltration of fibroblastic cells are key elements for the development of a congenital pseudarthrosis in the compu-
tational model. Hence, the computational model results have added credibility to the experimental hypothesis of 
a genetic cause (i.e. Nf1 mutation) for CPT. Future research efforts should be focused on the characterisation of 
the endochondral ossification pathway in Nf1 haploinsufficient and Nf1 bi-allelically inactivated cells and that of 
the in vivo fracture healing microenvironment of CPT patients as well as on the identification of other potential 
mechanisms of action in order to obtain a full understanding of the etiology of CPT and improve current treat-
ment strategies.
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